NOMPHARMA LIMITED
C51/100Summary
NOMPHARMA LIMITED is an active private limited company (company number 11764276) incorporated on 14 January 2019, registered in Nottingham. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest small accounts cover the period ending 31 January 2025, showing net assets of −£28k and cash of £1,910, with 0 employees on average. Net assets rose 16% on the prior period (−£33k).
By net assets it sits in the bottom quarter of 1,797 comparable companies in the UK (median £3,718, upper quartile £148k).
Key dates
- Incorporated
- 14 January 20197 yrs ago
- Next accounts due
- 31 October 2026in 9 days
- Confirmation statement due
- 28 January 2027in 98 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- SIC 96090
- Other service activities n.e.c.
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2025 | −£28k | £1,910 | £14k | £15k | — | — | 0 |
| 31 January 2024 | −£33k | £2,182 | £14k | £0 | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score
| 50 | Starting scoreEvery scored company starts here |
| −15 | Negative net assetsNet assets £-27,627 at 2025-01-31 |
| +8 | Net assets growing+16.0% vs prior period |
| +8 | EstablishedIncorporated 2019-01-14 (8 years) |
| 51 | Score, grade C |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
Ownership and control
- Mr Michael Nkanka
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mr Michael Nkanka
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mr Christopher Okwufulueze Chinakwe
- owns 75–100% of shares
- Mr Michael Nkanka
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Timeline
- Confirmation statement duein 98 days
- Next accounts duein 9 days
- Accounts period endNet liabilities £28k · small accounts
- Accounts period endNet liabilities £33k · small accounts
- Incorporated
Similar companies in Nottingham
- AQUA HYDRATION LIMITEDNottingham · inc. Jan 2019
- AVAIL GROUP UK LIMITEDNottingham · inc. May 2018
- BREDENT GROUP UK LTDNottingham · inc. Oct 2019
- N-PEN LTD.Nottingham · inc. Jan 2018
- BALAGRAE LTDNottingham · inc. Oct 2017
- GALEXA2020 LTDNottingham · inc. Jun 2020
All companies incorporated on 14 January 2019 · in Jan 2019.
Reminders for NOMPHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.